Pharmaceutical Technology
February 02, 2011
Issue PDF
35
2
Real Time Release Testing
February 02, 2011
Special Report
35
2
Chemistry reviewers in FDA's Office of Generic Drugs provide an overview of common deficiencies cited throughout the CMC section of ANDAs.
February 02, 2011
BioForum
35
2
Deep process characterization and "lab-on-a-chip" enable SMART bioprocess design.
February 02, 2011
From The Editor
35
2
Follow-ons were all the rage at this year's JP Morgan Healthcare Conference.
February 02, 2011
Special Report
35
2
Industry and regulatory experts discuss the challenges and benefits of implementing real time release testing in a pharmaceutical manufacturing environment.
February 02, 2011
PharmTech Talk
35
2
Government and private sector efforts take on counterfeit drugs online.
February 02, 2011
Ingredients Insider
35
2
Will 2011 be a more promising year for new molecular entities? A review of Big Pharma's late-stage pipeline shows what might lie ahead.
February 02, 2011
In the Spotlight
35
2
New products in tableting and granulation.
February 02, 2011
News
35
2
As biologic-drug patents move toward expiration in the US, Indian firms with experience in the follow-on biologics arena are eager to partner with global manufacturers and secure their place in the growing biosimilars market.
February 02, 2011
Viewpoint
35
2
Legislation has hampered cross-border drug importation and limited choice.
February 02, 2011
Industry Leaders
35
2
Q&A with Magnetrol International's Dan Klees
February 02, 2011
Washington Report
35
2
Food-safety, transparency, and counterfeit-drug growth will tax agency resources.
February 02, 2011
Outsourcing Outlook
35
2
More crucial biomanufacturing operations are expected to be outsourced.
February 02, 2011
Special Report
35
2
Anticounterfeiting solutions for vials and syringes.
February 02, 2011
News
35
2
USP helps to improve drug quality in 32 countries.
February 02, 2011
Agent-in Place
35
2
Taking care to note, file and re-check information can save one from future mishaps.
February 02, 2011
Statistical Solutions
35
2
Using risk assessment properly can provide industry with a unique tool for quality control.
February 02, 2011
Inside PIC/S
35
2
Nearly six years after applying, the FDA joins the Pharma Inspection Co-operation Scheme.
February 02, 2011
Online Exclusives
35
2
How to adapt a real time release approach to powder processing during drug-product manufacturing.
February 02, 2011
Special Report
35
2
The author describes why statistical significance would impose an unreasonable burden on manufacturers.
February 02, 2011
Peer Reviewed
35
2
The authors modified equipment and the manufacturing process to re-establish content uniformity among tablets.
February 02, 2011
Packaging Forum
35
2
Innovations protect the quality of temperature-sensitive products.
February 02, 2011
Online Exclusives
35
2
A roundtable moderated by Angie Drakulich.